Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials
Roni Nitecki, Alexander Melamed, Allison Gockley, Jessica L. Floyd, Kate J. Krause, Robert L. Coleman, Ursula A. Matulonis, Sharon H. Giordano, Karen H. Lu, J. Alejandro Rauh‐Hain
Topics & Concepts
MedicineMyeloid leukemiaMyelodysplastic syndromesIncidence (geometry)Internal medicinePoly ADP ribose polymeraseMeta-analysisRandomized controlled trialOncologyPolymeraseBone marrowEnzymeBiochemistryPhysicsOpticsChemistryPARP inhibition in cancer therapyAcute Myeloid Leukemia ResearchNeutropenia and Cancer Infections